BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31466583)

  • 1. Review and Update on Evidence-Based Surgical Treatment Recommendations for Nonmelanoma Skin Cancer.
    Shelton ME; Adamson AS
    Dermatol Clin; 2019 Oct; 37(4):425-433. PubMed ID: 31466583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curettage prior to Mohs' micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study.
    Jih MH; Friedman PM; Goldberg LH; Kimyai-Asadi A
    Dermatol Surg; 2005 Jan; 31(1):10-5. PubMed ID: 15720088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment of nonmelanoma skin cancer.
    Anthony ML
    AORN J; 2000 Mar; 71(3):552-4, 556-8, 560-4; quiz 565-70. PubMed ID: 10736640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.
    Rogers HW; Coldiron BM
    J Am Acad Dermatol; 2009 Jul; 61(1):96-103. PubMed ID: 19539843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmelanoma skin cancer of the head and neck: surgical treatment.
    Akcam TM; Gubisch W; Unlu H
    Facial Plast Surg Clin North Am; 2012 Nov; 20(4):455-71. PubMed ID: 23084298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining recurrence of nonmelanoma skin cancer after Mohs micrographic surgery: Report of the American College of Mohs Surgery Registry and Outcomes Committee.
    Leitenberger JJ; Rogers H; Chapman JC; Maher IA; Fox MC; Harmon CB; Bailey EC; Odland P; Wysong A; Johnson T; Wisco OJ
    J Am Acad Dermatol; 2016 Nov; 75(5):1022-1031. PubMed ID: 27546292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery.
    Lane JE; Kent DE
    Curr Surg; 2005; 62(5):518-26. PubMed ID: 16125611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of Mohs micrographic surgery: review of the literature.
    Tierney EP; Hanke CW
    J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Mohs micrographic surgery for nonmelanoma skin cancer: a systematic review protocol.
    Tokede O; Jadotte YT; Nkemjika S; Holly C; Cohen P; Schwartz R; Watkins A; Dellavalle R
    JBI Database System Rev Implement Rep; 2017 Mar; 15(3):666-675. PubMed ID: 28267028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery.
    Schell AE; Russell MA; Park SS
    JAMA Facial Plast Surg; 2013; 15(5):337-43. PubMed ID: 23744451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mohs micrographic surgery: a cost analysis.
    Cook J; Zitelli JA
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive guide to the surgical management of nonmelanoma skin cancer.
    Divine J; Stefaniwksy L; Reddy R; Padilla P; Hagele T; Patel NS; Cherpelis BS
    Curr Probl Cancer; 2015; 39(4):216-25. PubMed ID: 26364697
    [No Abstract]   [Full Text] [Related]  

  • 13. Indication guidelines for Mohs micrographic surgery in skin tumors.
    Cernea SS; Gontijo G; Pimentel ER; Tarlé RG; Tassara G; Ferreira JA; Fernandes VM; Bernardo WM
    An Bras Dermatol; 2016; 91(5):621-627. PubMed ID: 27828636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
    Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
    Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma.
    Chren MM; Sahay AP; Bertenthal DS; Sen S; Landefeld CS
    J Invest Dermatol; 2007 Jun; 127(6):1351-7. PubMed ID: 17301830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma.
    Chren MM; Linos E; Torres JS; Stuart SE; Parvataneni R; Boscardin WJ
    J Invest Dermatol; 2013 May; 133(5):1188-96. PubMed ID: 23190903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin Cancer in U.S. Elderly Adults: Does Life Expectancy Play a Role in Treatment Decisions?
    Linos E; Chren MM; Stijacic Cenzer I; Covinsky KE
    J Am Geriatr Soc; 2016 Aug; 64(8):1610-5. PubMed ID: 27303932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of curettage in delineating margins of basal cell carcinoma before Mohs micrographic surgery.
    Ratner D; Bagiella E
    Dermatol Surg; 2003 Sep; 29(9):899-903. PubMed ID: 12930329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mohs micrographic surgery for nonmelanoma skin cancer.
    Telfer NR
    Clin Dermatol; 1995; 13(6):593-600. PubMed ID: 8882771
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of dermoscopy in Mohs micrographic surgery (MMS) for nonmelanoma skin cancer (NMSC).
    Yeom SD; Lee SH; Ko HS; Chung KY; Shin J; Choi GS; Byun JW
    Int J Dermatol; 2017 Jun; 56(6):e136-e139. PubMed ID: 28247925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.